We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Improved PFS and OS With Ixazomib Plus Lenalidomide-Dexamethasone (IRd) vs Placebo-Rd in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM): Final Data From the Phase 3 China Continuation of TOURMALINE-MM1.
- Authors
Hou, Jian; Jin, Jie; Xu, Yan; Wu, Depei; Ke, Xiaoyan; Daobin, Zhou; Lu, Jin; Du, Xin; Chen, Xiequn; Li, Junmin; Liu, Jing; Gupta, Neeraj; Hanley, Michael; Li, Hongmei; Hua, Zhaowei; Wang, Bingxia; Zhang, Xiaoquan; Wang, Hui; van de Velde, Helgi; Richardson, Paul
- Publication
Clinical Lymphoma, Myeloma & Leukemia, 2017, Vol 17, pe67
- ISSN
2152-2650
- Publication type
Article
- DOI
10.1016/j.clml.2017.03.121